Search results

The 5th Ecumenical Pilgrimage for Climate Justice from Poland to Glasgow crossed the English Channel from IJmuiden in the Netherlands to Newcastle-upon-Tyne in England on 11 October. They were given a warm welcome on site. 

On 26 July at the International AIDS Conference in Amsterdam, there was a marked change in colour at the Interfaith Networking Zone. It was Thursday, and from morning prayers to the evening informal networking, the theme was “black”.

Every two years, the International AIDS Conference provides scientists with a venue to announce new discoveries in how HIV is diagnosed and treated. This year, the 23-27 July conference, held in Amsterdam, was no exception.

Faith-based organizations have been at the forefront of calls to accelerate HIV testing and treatment for children and adolescents. As gaps in infection and treatment between adults and children have become more apparent, there are now more concerted efforts to “super fast-track” services for children. But will they be enough?

A symbolic bridge, carefully constructed over a two-day interfaith conference, connects an interfaith networking zone with a space shared with the World Health Organization (WHO), UNAIDS and Unitaid at the Global Village of the International AIDS Conference 2018.

“Science is important. But social change is needed, and social change happens with faith–based organizations.”

How faith groups and leaders can, should and are building bridges to more effectively eliminate AIDS as a public health threat is the focus of an interfaith event being held in Amsterdam, 21-22 July 2018.

The World Council of Churches - Ecumenical Advocacy Alliance endorses a newly expanded collaboration on HIV between the Medicine Patent Pool and Gilead. On 4 October, the MPP announced a licence with Gilead Sciences for bictegravir, a new integrase inhibitor part of a once-daily, single-tablet HIV regimen currently filed for regulatory approval at the United States Food and Drug Administration and the European Union.